Search Results
Site Search
Whole exome sequencing - Insights
Learn more about how whole exome sequencing at Mayo Clinic Laboratories can quickly end diagnostic testing odysseys for patients with suspected genetic disorders.
Mayo Clinic Laboratories’ comprehensive dementia testing menu includes evaluations for Alzheimer's disease, autoimmune dementia, and rapidly progressive dementia.
Preparation of Platelet-Poor Plasma for Special Coagulation Testing - Insights
In this months "Hot Topic," Christopher Desens, MLS(ASCP) discusses the preparation of platelet-poor plasma for coagulation testing.
Check out how Mayo Clinic Laboratories’ full menu of B-cell lymphoma testing, which includes next-generation sequencing and FISH testing, can inform diagnosis and prognosis for patients.
Laboratory Testing of Bone Turnover Markers - Insights
In this “Hot Topic,” Alicia Algeciras-Schimnich, Ph.D., professor of laboratory medicine and pathology at Mayo Clinic, discusses the role of bone turnover markers in osteoporosis treatment as well as how to best interpret changes in bone...
A team of Mayo Clinic pathologists have discovered a new tissue biomarker, DNAJB9, for fibrillary glomerulonephritis, a rare kidney disease of unknown pathogenesis and poor outlook—nearly half of all patients end up on dialysis within four...
Frequently asked questions - Insights
Read answers to frequently asked questions about prenatal testing at Mayo Clinic Laboratories, including specimen requirements, maternal cell contamination testing, pricing, and more.
Next-generation sequencing: Examining an often oversimplified & misunderstood technology--Part I
In the last decade, genetic testing has evolved from single-gene Sanger based assays to much more complex next-generation sequencing (NGS) based assays.
Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.
Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.
Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.
Finding the Balance: Legal Issues Arising from Precision Medicine - Insights
By taking into account an individual’s genes, lifestyle, and environment, precision medicine offers the prospect of finding individualized therapies that might ultimately cure diseases such as cancer and diabetes. Yet, as with other...
Jeff Meeusen, Ph.D., Provides Clinical Update on Ceramides - Insights
Jeff Meeusen, Ph.D., Co-Director of Cardiovascular Laboratory Medicine in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester, Minnesota, provides a clinical update on ceramides.
Relentless innovation - Insights
Inspired by Mayo Clinic’s history of breaking down barriers to change medicine, we are constantly reimagining what’s possible in diagnostics.
Medical Drones: High Hopes, Grounded in Science - Insights
While online retailers experiment with drones as a way to swiftly deliver consumer purchases, laboratory medicine physicians and scientists have a lifesaving goal: using drones to rapidly deliver laboratory specimens.
Frozen and on Time: Rapid Margin Assessment Helps Prevent Repeat Surgeries - Insights
A breakthrough in pathology, achieved more than a century ago (allegedly on a frozen window ledge in Rochester, Minnesota) has evolved into an innovative aspect of care at Mayo Clinic. Mayo is one of the only medical centers in the United...
In this month's "Hot Topic," Robin Patel, M.D., discusses how the use of multiplex tests may reduce the turnaround time for identifying the cause of bloodstream infections, and how this might impact antibiotic stewardship and patient...
Offering more than 150 oncology-specific tests in nine subspecialty areas, Mayo Clinic Laboratories’ cancer tests are developed by an experienced team of board-certified geneticists, genetic counselors, and physicians.
Revolutionizing Endometrial Cancer Diagnostics - Insights
Endometrial cancer affects thousands annually and ranks as the fourth most common cancer among women in the United States. At the forefront of innovative discoveries in endometrial cancer diagnostics are Mayo Clinic's Department of...
The Living Breast Biobank - Insights
This unique Mayo Clinic resource offers a novel portal into the study of gene mutations before they cause breast cancer.
Glimmer of Hope: Gregor Heinrich - Insights
While Gregor Heinrich never could have imagined that testicular cancer was related to his problems with his vision and gait, learning he was positive for KLHL11 protein biomarkers meant he could receive treatment for both the cancer and the...
UofL Health – UofL Hospital physicians and laboratory scientists faced challenges in the ordering of autoimmune and paraneoplastic panels: duplicate orders that add unnecessary cost and omitted test orders that could provide the key to the...
Kootenai Health: Recapturing their market through precision coordination - Insights
Prevented from providing testing services to its community members due to a non-compete agreement with a national laboratory, Kootenai Health laboratory leaders deepened their relationship with Mayo Clinic Laboratories, receiving tactical...
Avoid seller's remorse: Why owning your lab makes sense - Insights
For community health care providers, owning a laboratory has been likened to shoveling money down a giant drain. Cayuga Medical Center is challenging that narrative. Instead of selling, Cayuga is investing in its lab — which it considers a...
Transformative diagnostics - Insights
With a sophisticated laboratory test catalog and thousands of Mayo Clinic experts, we’re here to help you answer the toughest clinical questions.
Mayo Clinic Laboratories’ newly expanded Hereditary Pancreatitis Gene Panel is transforming how clinicians diagnose and manage a complex, often elusive disease. Developed through close collaboration between lab scientists, genetic...
Living in the moment: Susan Parrott - Insights
As someone affected by chronic liver disease, Susan Parrott knows how it feels to live in uncertainty. But every few months, the anxiety and doubt that shadow her life fade when Mayo Clinic Laboratories test results confirm her condition is...
An order-entry, clinical decision support tool developed by physicians and scientists at Froedtert and the Medical College of Wisconsin (MCW) for clinicians within the healthcare system who order autoimmune and paraneoplastic antibody...
Specialized testing helps reverse effects of stiff-person syndrome: James Kypuros - Insights
One summer morning, James Kypuros awoke to find his toes stiffened like claws. Then he started having falls, which culminated in losing his ability to walk or even sit up without help. Diagnosed with stiff-person syndrome, James wouldn’t...
Against the odds: Alex Kraatz - Insights
As a two-time brain tumor survivor, Alex Kraatz has been through more harrowing medical experiences in his 34 years than most people face in a lifetime. But Alex’s fighting spirit, coupled with precision laboratory testing and cutting-edge...
How digital pathology provides faster answers - Insights
Almost four years ago, Mayo Clinic launched the Digital Pathology Program, a major pathology initiative. Phase 2 of this multi-phase rollout has recently been completed, which involved the implementation of cutting-edge digital equipment...
Leveraging technology to transform Anatomic Pathology - Insights
As Mayo Clinic’s Anatomic Pathology moves from traditional glass slides to digital images, the advance in technology is achieving clear benefits in collaboration, learning, and patient care.
Ceramide testing helps reduce risk of heart attack: Stephanie Blendermann - Insights
Her father was a heavy smoker who eventually needed bypass surgery for his clogged arteries, and three of her sisters died prematurely from heart attacks. So, as Stephanie Blendermann approached the age of 65, she had good reason to think...
MCL @Work: Sarah Mason - Insights
In her current role as senior manager for global logistics at Mayo Clinic Laboratories, Sarah Mason oversees the coordination of patient sample shipments by working with a network of stakeholders, couriers, carriers, and vendors. Sarah...
A decade-long search for answers ends at Mayo Clinic: Tyler Hart - Insights
After years of misdiagnosis, Tyler Hart found answers at Mayo Clinic, discovering he had NF155-IgG4 autoimmune nodopathy instead of CIDP
Unraveling a diagnostic mystery: Ed Garber - Insights
Ed Garber spent months in physical and neurological decline while a cohort of care providers and specialists searched for the root cause of his symptoms. That search for answers ended after testing by Mayo Clinic Laboratories gave them the...
An uncommon antibody, a life restored: Jori Pearson - Insights
Sophisticated laboratory testing solved a medical riddle and finally got Jori Pearson back on his feet, doing what he loves.
A downward spiral undone: Jon Bratsch - Insights
Lying in an ICU bed as sick as he could get, Jon Bratsch thought he was past the point of no return. But when a Mayo Clinic Laboratories’ test revealed the source of his dire symptoms, everything changed. Today, Jon’s back to the life and...
Seeking, and finding, answers, comfort, and hope: Joe Mondloch - Insights
Joe Mondloch and his wife Sue have existed in a grey area of uncertainty due to the unpredictable autoimmune neurological illness Joe has lived with for the last seven years. Rare, incurable, and debilitating, the newly classified disorder...
MCL @Work: Robin Huiras-Carlson - Insights
Robin Huiras-Carlson's connection with Mayo Clinic traces back to her early years, marked by a diagnosis of a rare genetic condition at the age of 10. Today, as a senior marketing specialist with Mayo Clinic Laboratories, she draws...
New tests launched in March - Insights
In March 2023, Mayo Clinic Laboratories announced twenty nine new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New tests launched in June - Insights
In June 2022, Mayo Clinic Laboratories announced forty-nine new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Hospitals and health systems - Insights
Mayo Clinic Laboratories can help hospital laboratories leverage the power of their labs through advanced, high-quality testing, customized consultative services, and tailored business solutions.
A Mayo Clinic BioPharma Diagnostics engagement offers partners access to Mayo Clinic Laboratories’ robust library of hematology evaluations.
Krabbe disease added to federal newborn screening panel - Insights
Thanks to advocacy work by a group of medical experts, including some from Mayo Clinic, the U.S. Department of Health and Human Services now recommends all states screen for infantile Krabbe disease to help save newborn lives.
For Billy Dowell Jr., a competitive golfer, focus, determination, and course correction are essential to excelling at the sport. These skills, along with routine follow-up care and testing, are also important to navigating a life impacted...
Ceramide testing helps shape individualized heart health treatment plan: Mark Kocak - Insights
An avid runner and fitness buff, Mark Kocak didn’t think he needed medication for his high cholesterol and hypertension. After coming to Mayo Clinic for ceramide testing, Mark knew exercise alone would not be enough to him on a path toward...
Converging on a major milestone in digital pathology - Insights
Successful implementation of a new slide scanning and analysis platform across five laboratories represents a significant step forward in Mayo Clinic’s digital pathology program — an initiative that combines advanced technology with human...
A shared journey through breast cancer: Samantha Duke and Jane Hanson - Insights
When Samantha Duke discovered she had breast cancer, she didn’t have to look far for support. Her mother Jane walked a similar path 16 years earlier. Inspired both by her mom and the strong network of healthcare physicians and professionals...
Infectious diseases - Insights
Mayo Clinic BioPharma Diagnostics offers access to the clinical trial infectious disease testing capabilities of Mayo Clinic’s internationally renowned clinical microbiology laboratories. With more than 70 years of testing experience, our...